Convergence selects Evotec to help develop pain treatment
Convergence Pharmaceuticals has entered into a research alliance with CRO Evotec to discover and develop compounds against a novel GPCR pain target.
Archives for March 31, 2014
Lupin: Mexican buy a bridgehead to generics and API growth
Lupin has bought Mexican eye drugmaker Grin in a deal that gives it a “bridgehead” to grow its API and generics business in the region.
Dispatches from DIA Euromeeting
Expert: ‘We lack the regulatory models’ for next generation drugs
The pharmaceutical industry lacks the regulatory models to govern sweeping changes in the near future surrounding combination products and large molecule drugs, said an expert at DIA Euromeeting in Vienna last week.
Quality and IP issues driving sponsors away from Indian CMOs, experts say
Quality and IP issues are driving firms back to the US and Europe for their contract manufacturing according to experts, but Kemwell says there are still opportunities for Indian CMOs.
'Biodegradable battery' could be used to deliver drugs, researcher says
An intracochlear drug delivery implant could be powered over several months by a biodegradable battery according to an expert.
CROs further consolidate: Icon scoops up Aptiv for $144M
Ireland-based CRO Icon has agreed, subject to certain closing conditions, to acquire Aptiv Solutions for $143.5m in cash to further expand its adaptive trial offerings.
Quintiles to run sales team if opioid dependence drug approved
US-based BioDelivery Sciences International (BDSI) has selected Quintiles to provide a range of services to support the expected launch of Bunavail (buprenorphine and naloxone buccal film), a maintenance treatment for opioid dependence.
Cobra's French mAb customers to get R&D tax credit
French mAb developers that hire Cobra Biologics stand to benefit from tax breaks after the French Ministry of Higher Education and Research (MESR) named the CMO as a preferred provider.
UPDATE
GSK issues recall after Irish API plant slammed by US FDA Warning Letter
GlaxoSmithKline has issued a recall of its antidepressant drug Paxil after receiving a US FDA Warning Letter for failing to fully investigate contamination issues at an Irish API plant.
Portable tech advancing fight against counterfeits, says MHRA
Making API detecting technologies more portable has been a major development in the fight against counterfeit drugs, according to the MHRA, though the biggest threat comes from online sellers.